Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: results of the HOVON 76 Trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples